| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
BioNexus Gene Lab Corp
13G
BGLC · 090628306
|
13.4% |
10/22/2026
Event 11/28/2025
|
||||
| Fidelion Diagnostics Pte. Ltd. | 13.4% | |||||
| Molecule Bio LLC | 13.4% | |||||
| Xiao Ling | 13.4% | |||||
| Rainy Morning Technology (Hong Kong) Limited | 13.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.